NM_000303.3:c.722G>C
Variant summary
The NM_000303.3(PMM2):c.722G>C (p.Cys241Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The gene PMM2 is a cancer driver gene (CancerMine: 2 driver citations). The variant allele was found at a cumulative frequency of 0.0000645 (AC=104) in the gnomAD database across 1,613,056 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000582. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.25). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000633728: Experimental studies have shown that this missense change affects PMM2 function (PMID:11715002, 21541725, 22012410, 26014514)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C241R: Likely_pathogenic (ClinVar VariationId 2847057, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000303.3 missense
Scores
Clinical Significance
Conservation
Publications
- congenital disorder of glycosylation type IInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
- PMM2-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Natera, PanelApp Australia, Orphanet, ClinGen
- hyperinsulinemic hypoglycemia with polycystic kidney diseaseInheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 8 pathogenic, 1 benign (OR vs. background: 28.3); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -1.80 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000303.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMM2 | MANE Select | c.722G>C p.Cys241Ser | missense | Exon 8 of 8 | Prot: NP_000294.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMM2 | TSL:1MANE Select | c.722G>C p.Cys241Ser | missense | Exon 8 of 8 | Prot: ENSP00000268261.4 UniProt: | |
PMM2 | TSL:1 | n.*340G>C | 3_prime_UTR | Exon 6 of 6 | Prot: ENSP00000457932.1 UniProt: | |
PMM2 | TSL:1 | n.*344G>C | 3_prime_UTR | Exon 6 of 6 | Prot: ENSP00000454284.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000243 | AC:37 | Hom:0 | AN:152224 | Cov:33 |
GnomAD2 exomes | AF: 0.0000598 | AC:15 | AN:250796 | ||
GnomAD4 exome | AF: 0.0000459 | AC:67 | Hom:0 | AN:1460832 | Cov:30 |
GnomAD4 genome | AF: 0.000243 | AC:37 | Hom:0 | AN:152224 | Cov:33 |
TOPMed (Bravo) | AF: 0.000212 | AC:56 | Hom:1 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000279 | AC:8 | Hom:0 | AN:28638 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.0000477 | 2 | 41958 | 0.000105 | 7 | 66878 |
SCHEMA | 0.0000798 | 9 | 112744 | 0.0000474 | 9 | 190044 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.74 | |
BayesDel_addAF | Pathogenic | 0.30 | D |
BayesDel_noAF | Pathogenic | 0.55 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Pathogenic | 0.91 | D |
Eigen | Pathogenic | 0.75 | |
Eigen_PC | Uncertain | 0.66 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
GPN-Star LLR | N/A | -5.6 | |
GPN-Star score | N/A | 5.6 | |
LIST_S2 | Uncertain | 0.93 | D |
M_CAP | Pathogenic | 0.36 | D |
MetaRNN | Pathogenic | 0.90 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 3/97 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.1 | M |
PhyloP100 | Pathogenic | 8.3 | |
popEVE | Benign | -3.0 | |
PrimateAI | Uncertain | 0.68 | T |
PROVEAN | Uncertain | -3.0 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Pathogenic | 0.93 | |
Sift | Benign | 0.042 | D |
Sift4G | Benign | 0.21 | T |
Varity_R | N/A | 0.94 | |
VESM-3B | Benign | -8.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.